Etonogestrel
- Generic Name
- Etonogestrel
- Brand Names
- Eluryng, Enilloring, Implanon, Nexplanon, Nuvaring
- Drug Type
- Small Molecule
- Chemical Formula
- C22H28O2
- CAS Number
- 54048-10-1
- Unique Ingredient Identifier
- 304GTH6RNH
- Background
Etonogestrel molecule is a 3-ketodesogestrel or 19-nortestosterone which is a synthetic biologically active metabolite of progestin desogestrel. The first product including etonogestrel was developed by the Merck subsidiary Organon and FDA approved in 2001.
- Indication
Etonogestrel is administered in subdermal implants as long-acting reversible contraception. It is known to be effective in postpartum insertion including breastfeeding women.
Etonogestrel is part of the long-acting contraceptive implants that prevent pregnancy. The implant's effect can remain for 5 years.
- Associated Conditions
- -
- Associated Therapies
- Contraception, Contraceptive implant therapy
Etonogestrel Implants Protect Ovarian Reserve Function in Systemic Lupus Erythematosus
- First Posted Date
- 2023-03-30
- Last Posted Date
- 2023-03-30
- Target Recruit Count
- 180
- Registration Number
- NCT05791799
Breastfeeding Etonogestrel Implant Study
- First Posted Date
- 2019-06-07
- Last Posted Date
- 2024-10-26
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 150
- Registration Number
- NCT03978598
- Locations
- 🇺🇸
University of Utah, Salt Lake City, Utah, United States
🇺🇸University of New Mexico, Albuquerque, New Mexico, United States
Abnormal Uterine Bleeding and Progestin-only Contraceptives
- Conditions
- Interventions
- First Posted Date
- 2018-01-12
- Last Posted Date
- 2020-12-17
- Lead Sponsor
- Assiut University
- Target Recruit Count
- 390
- Registration Number
- NCT03398811
- Locations
- 🇪🇬
Women Health Hospital - Assiut university, Assiut, Egypt
Clinical Trial the Use of Levonorgestrel-releasing Intrauterine System Versus Etonogestrel Implant in Endometriosis
- First Posted Date
- 2015-06-24
- Last Posted Date
- 2017-08-14
- Lead Sponsor
- University of Campinas, Brazil
- Target Recruit Count
- 100
- Registration Number
- NCT02480647
- Locations
- 🇧🇷
Nelsilene Mota Carvalho, Campinas, São Paulo, Brazil
A Pharmacokinetic Evaluation of Etonogestrel (ENG) Implant and Antiretroviral Therapy
- First Posted Date
- 2014-03-10
- Last Posted Date
- 2017-09-14
- Lead Sponsor
- University of Pittsburgh
- Target Recruit Count
- 60
- Registration Number
- NCT02082652
- Locations
- 🇺🇬
Infectious Disease Institute, Kampala, Uganda
A Trial to Investigate the Effectiveness and Safety of Org 3236 (Etonogestrel) Tablets in Men With Urinary Complaints Suggestive of a Benign Enlargement of the Prostate (304001)(P05806)
- Conditions
- Interventions
- First Posted Date
- 2008-04-03
- Last Posted Date
- 2022-02-04
- Lead Sponsor
- Organon and Co
- Target Recruit Count
- 16
- Registration Number
- NCT00651807
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.